亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

湖北藥業集團  

肉桂酸、肉桂醛、肉桂醇,地塞米松、強的松、丙酸氯倍他索、曲安奈德、皮質激素、甾體激素、西地那非、他達那非、金陽堿、新陽堿、十一酸睪酮、丙酸睪酮、雄烯二醇、醋酸睪酮、苯丙酸諾龍、苯丙酸睪酮、庚酸睪酮、異己酸睪酮、雌二醇、癸酸睪酮、癸酸諾龍、睪酮

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:黃然
  • 電話:02788060561
  • 郵件:aoxone@qq.com
  • 傳真:02788048077
  • QQ:2241693900
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 奧美拉唑硫醚73590-85-9
奧美拉唑硫醚73590-85-9
單價 面議對比
詢價 暫無
發貨 湖北武漢市付款后3天內
品牌 73590-85-9
型號 73590-85-9
規格 73590-85-9
過期 長期有效
更新 2012-02-18 08:43
 
詳細信息
奧美拉唑硫醚
中文別名:優菲那唑,烏菲拉唑
英文名稱:Omeprazole Sulfide
化學全名是:5-甲氧基-2-(4-甲氧基-3,5-二甲基-2-吡啶基)甲基硫代-1H-苯并咪唑;
英文化學全名:2-{[(3,5-Dimethyl-4-methoxy-2-pyridinyl)-methyl]-thio}-5-methoxy-1H-benzimidazole。
奧美拉唑硫醚CAS:73590-85-9
分子式:C17H19N3O2S
分子量:329.42
外觀:米色或淡黃色結晶粉末
奧美拉唑硫醚規格型號:醫藥級99.5%
包裝規格:1kg/鋁箔袋
奧美拉唑硫醚用途:埃索美拉唑鈉中間體。
©2025 湖北藥業集團 版權所有   技術支持:化工網   訪問量:8673  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |